feed,title,long_url,short_url
Benzinga,Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops,https://benzinga.com/general/biotech/21/07/21852895/provention-bios-teplizumab-application-receives-crl-for-type-1-diabetes-stock-drops,https://j.mp/2Tz3uQ2
